Contraceptive Coverage Mandate: New Health Plan Rules
- Brazil considerably broadened access to the highly effective long-acting reversible contraceptive (LARC) Implanon on Monday, July 1, 2024, mandating coverage by private health plans and preparing for widespread...
- The decision by the National Supplementary Health Agency (ANS) to require coverage of Implanon in private health plans directly follows a parallel announcement from the Ministry of Health...
- This dual approach-expanding access through both private and public sectors-signals a important commitment to reproductive health in Brazil.
“`html
Implanon Coverage Expands in Brazil: A New Era for Contraceptive Access
Table of Contents
Brazil considerably broadened access to the highly effective long-acting reversible contraceptive (LARC) Implanon on Monday, July 1, 2024, mandating coverage by private health plans and preparing for widespread distribution within the public healthcare system (SUS).
National Supplementary Health Agency (ANS) Ruling
The decision by the National Supplementary Health Agency (ANS) to require coverage of Implanon in private health plans directly follows a parallel announcement from the Ministry of Health regarding its inclusion in the Unified Health System (SUS). The Ministry of Health announced the initiative on June 28, 2024, aiming to provide a wider range of contraceptive options to Brazilian women.
This dual approach-expanding access through both private and public sectors-signals a important commitment to reproductive health in Brazil. The Ministry of Health intends to make 500,000 Implanon units available through SUS later this year,addressing a critical need for effective contraception.
Who is Eligible for Implanon Coverage?
Coverage by private health plans is guaranteed for women aged 18 to 49 years with a medical indication for preventing unintended pregnancy. This age range reflects the reproductive years for most women and ensures access to a highly effective method for family planning. The ANS ruling clarifies that plans must cover the implant’s insertion and removal procedures.
The implant is contraindicated in specific situations, including a history of certain cancers, unexplained vaginal bleeding, severe liver disease, and active thromboembolic disease. The Ministry of Health provides detailed contraindication information on its website.
Understanding Implanon: Effectiveness and Mechanism
Implanon is a small, flexible plastic rod inserted under the skin of the upper arm.It releases a progestin hormone (etonogestrel) that prevents pregnancy for up to three years. Its effectiveness is greater than 99%, making it one of the most reliable forms of contraception available. Planned Parenthood details the mechanism of action and benefits of Implanon.
Unlike daily pills or monthly injections, Implanon requires only a single insertion, eliminating the need for ongoing adherence. This is particularly beneficial for women who may face challenges with consistent contraceptive use.
| Contraceptive method | Typical Use Effectiveness (%) | Perfect Use Effectiveness (%) |
|---|---|---|
| Implanon | >99% | >99% |
| Combined Oral Contraceptives (Pills) | 91% | 99% |
| Male Condoms | 87% | 98% |